Sign In
Buy IRIX
$1.18
+0 (+0%)
At Close: Jun 23, 2026
IRIDEX Launches Revised MicroPulse P3® Device for Glaucoma
09:03pm, Wednesday, 26'th Feb 2020
IRIDEX Corporation (IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today the introduction of the second generatio
IRIDEX Launches Revised MicroPulse P'® Device for Glaucoma
12:00am, Wednesday, 26'th Feb 202094 Biggest Movers From Yesterday
10:13am, Wednesday, 12'th Feb 2020
Gainers
Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) shares gained 78.5% to close at $3.66 after the company announced a license agreement with Zhejiang HaiChang Biotechnology....
Perkins Capital Management Inc Buys Aspen Group Inc, Qumu Corp, Akoustis Technologies Inc, ...
12:00am, Monday, 03'rd Feb 2020Should You Be Concerned About IRIDEX Corporation's (NASDAQ:IRIX) Historical Volatility?
01:05pm, Friday, 24'th Jan 2020
Anyone researching IRIDEX Corporation (NASDAQ:IRIX) might want to consider the historical volatility of the share...
Mid-Afternoon Market Update: Dow Turns Lower; Stemline Therapeutics Shares Plummet
07:15pm, Tuesday, 14'th Jan 2020
Toward the end of trading Tuesday, the Dow traded down 0.05% to 28,893.91 while the NASDAQ fell 0.34% to 9,242.31. The S&P also fell, dropping 0.28% to 3,278.76.
Leading and...
Mid-Day Market Update: GameStop Falls Following Soft 2019 Holiday Sales; RTI Surgical Shares Climb
05:26pm, Tuesday, 14'th Jan 2020
Midway through trading Tuesday, the Dow traded up 0.38% to 29,018.33 while the NASDAQ rose 0.01% to 9,274.37. The S&P also rose, gaining 0.01% to 3,288.18.
Leading and Lagging...
IRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2019
09:05pm, Monday, 13'th Jan 2020
IRIDEX Corporation (IRIX) today provided preliminary operational and financial results for the fourth quarter and full year ended December 28, 2019. Total revenue for the fourth quarter of 2019 expec
IRIDEX Sees Prelim. Q4 Sales $11.6M-$11.8M vs $10.88M Est., Sees Prelim. FY19 Sales $43.3M-$43.5M vs $42.57M Est.
12:00am, Monday, 13'th Jan 2020IRIDEX Corporation's (NASDAQ:IRIX) Shift From Loss To Profit
02:08pm, Tuesday, 10'th Dec 2019
IRIDEX Corporation's (NASDAQ:IRIX): IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic...
Edited Transcript of IRIX earnings conference call or presentation 7-Nov-19 10:00pm GMT
06:35pm, Friday, 29'th Nov 2019
Q3 2019 IRIDEX Corp Earnings Call
